ShockWave Medical, Inc. (SWAV)

NASDAQ: SWAV · IEX Real-Time Price · USD
263.41
+2.54 (0.97%)
At close: Mar 1, 2024, 4:00 PM
261.00
-2.41 (-0.91%)
After-hours: Mar 1, 2024, 7:45 PM EST
0.97%
Market Cap 9.85B
Revenue (ttm) 730.23M
Net Income (ttm) 147.28M
Shares Out 37.40M
EPS (ttm) 3.85
PE Ratio 68.42
Forward PE 52.44
Dividend n/a
Ex-Dividend Date n/a
Volume 362,918
Open 263.27
Previous Close 260.87
Day's Range 258.64 - 264.32
52-Week Range 157.00 - 315.95
Beta 0.88
Analysts Buy
Price Target 260.08 (-1.26%)
Earnings Date Feb 15, 2024

About SWAV

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Mar 7, 2019
Employees 1,468
Stock Exchange NASDAQ
Ticker Symbol SWAV
Full Company Profile

Financial Performance

In 2023, SWAV's revenue was $730.23 million, an increase of 49.11% compared to the previous year's $489.73 million. Earnings were $147.28 million, a decrease of -31.81%.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for SWAV stock is "Buy." The 12-month stock price forecast is $260.08, which is a decrease of -1.26% from the latest price.

Price Target
$260.08
(-1.26% downside)
Analyst Consensus: Buy
Stock Forecasts

News

Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results

SANTA CLARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

17 days ago - GlobeNewsWire

Shockwave Medical Appoints Renee Gaeta as Chief Financial Officer

SANTA CLARA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

4 weeks ago - GlobeNewsWire

Shockwave Medical Provides Quarterly Earnings Release Dates for 2024

SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- January 8, 2024 – Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for...

7 weeks ago - GlobeNewsWire

Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

SANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car...

2 months ago - GlobeNewsWire

Shockwave Medical to Participate in the Piper Sandler 35th Annual Healthcare Conference

SANTA CLARA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car...

3 months ago - GlobeNewsWire

New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women And Men

One-Year Outcomes Published in JSCAI Confirm Excellent, Consistent IVL Safety and Effectiveness Across Sexes One-Year Outcomes Published in JSCAI Confirm Excellent, Consistent IVL Safety and Effective...

4 months ago - GlobeNewsWire

Shockwave Medical Reports Third Quarter 2023 Financial Results

SANTA CLARA, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

4 months ago - GlobeNewsWire

Centers for Medicare & Medicaid Services Establishes New Category I CPT® Add-On Code for Coronary IVL

SANTA CLARA, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

4 months ago - GlobeNewsWire

Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2023 Results and Participation in Upcoming Investor Conference

SANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car...

4 months ago - GlobeNewsWire

Shockwave Medical Introduces Enhanced Coronary IVL Catheter in the United States

Shockwave C2+ Debut Joins Packed Shockwave Agenda at Transcatheter Cardiovascular Therapeutics Conference in San Francisco

4 months ago - GlobeNewsWire

New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies

Clinical Research Validates Utility of IVL in Complex Nodular and Eccentric Calcium Clinical Research Validates Utility of IVL in Complex Nodular and Eccentric Calcium

4 months ago - GlobeNewsWire

Shockwave Medical to Livestream 2023 Investor Innovation Day

SANTA CLARA, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

5 months ago - GlobeNewsWire

Shockwave Medical Appoints Nick West as Associate Chief Medical Officer

SANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of...

6 months ago - GlobeNewsWire

Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024

SANTA CLARA, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of...

6 months ago - GlobeNewsWire

Shockwave Medical to Participate in Upcoming Investor Conferences

SANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car...

6 months ago - GlobeNewsWire

Shockwave Medical Prices Upsized Private Offering of $650.0 Million of 1.00% Convertible Senior Notes Due 2028

SANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave Medical”) announced today the pricing of its offering of $650.0 million aggregate principal am...

7 months ago - GlobeNewsWire

Shockwave Medical Announces Proposed Private Offering of $500.0 Million of Convertible Senior Notes

SANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave Medical”) announced today that it intends to offer, subject to market conditions and other fac...

7 months ago - GlobeNewsWire

Shockwave Medical Reports Second Quarter 2023 Financial Results

SANTA CLARA, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

7 months ago - GlobeNewsWire

Centers For Medicare & Medicaid Services Creates New Hospital Inpatient Payment for Coronary Intravascular Lithotripsy

Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into Effect October 1, 2023 Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into E...

7 months ago - GlobeNewsWire

Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2023 Results and Participation in Upcoming Investor Conference

SANTA CLARA, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car...

8 months ago - GlobeNewsWire

Shockwave Medical Publishes 2022 ESG Report

SANTA CLARA, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of c...

9 months ago - GlobeNewsWire

Shockwave Appoints Kevin Ballinger to Board of Directors

SANTA CLARA, Calif., May 17, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of c...

10 months ago - GlobeNewsWire

Shockwave Medical, Fast Grower, In Boston Scientific's Sights?

Shockwave Medical Inc. NASDAQ: SWAV, the largest component within the iShares Russell 2000 ETF NYSEARCA: IWM, briefly cleared a cup-with-handle buy point on May 12, but reversed lower along with the b...

Other symbols: BSX
10 months ago - MarketBeat

Shockwave Medical Launches New Coronary IVL Catheter Internationally and Enrolls First Patient in All-Female Empower Study

Shockwave C 2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries SANTA CLARA, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development...

10 months ago - GlobeNewsWire

Shockwave Medical Reports First Quarter 2023 Financial Results

SANTA CLARA, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex cal...

10 months ago - GlobeNewsWire